A case of pulmonary infection with Mycobacterium fortuitum during chemotherapy for lung cancer
Hiroki Tashiro Koichiro Takahashi Go Kato Kazutoshi Komiya Naoko Sueoka-Aragane Shinichiro Hayashi
Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University
A 53-year-old man receiving chemotherapy for lung cancer was admitted to Saga University Hospital for evaluation of fever and pulmonary infiltration on chest radiograph. He was diagnosed as acute pulmonary mycobacteriosis caused by M. fortuitum. Combination therapy using amikacin and levofloxacin for 6 months led to improvement of radiological and bacteriological findings. There have been some reports of pulmonary M. fortuitum infection during cancer chemotherapy using cytotoxic agents. Our experience with the present case extends this knowledge and suggests that attention should be paid to possible acute mycobacterium infection during chemotherapy.
Mycobacterium fortuitum Lung cancer Chemotherapy
Received 8 Nov 2013 / Accepted 6 Jan 2014
AJRS, 3(3): 438-441, 2014